IDURONIDASE, .ALPHA.-L-(8-HISTIDINE) (HUMAN)
Mucopolysaccharidosis I
University of California, San Franciscoprotein_peptidePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Mucopolysaccharidosis I cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Aldurazyme Genzyme, a Sanofi Company | Phase 4 | A |
Rhidu Genzyme, a Sanofi Company | Phase 3 | BB |
VALANAFUSP ALFA ArmaGen, Inc | Phase 1/2 | BB |
Equine Atg Masonic Cancer Center, University of Minnesota | Phase 2 | B |
Genotropin Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Phase 2/3 | B |
View all 15 →
Same molecule, other indications
IDURONIDASE, .ALPHA.-L-(8-HISTIDINE) (HUMAN) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →